Rafed and G42 Healthcare sign agreement for the management and storage of COVID-19 vaccines

Friday, February 19, 2021

Rafed, a healthcare group purchasing organization that is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy, has signed a new agreement with G42 Healthcare, a leading healthcare technology company and a subsidiary of Abu Dhabi-based Group 42,to provide state-of-the-art services that include the provision of storage facilities for COVID-19 vaccines.

As part of the agreement between the two Abu Dhabi entities, Rafed will oversee the logistics including the management, transportation, and storage of the vaccine doses in the new designated facilities, in line with the requirements and standards of Abu Dhabi’s Department of Health.

Rafed distribution centre is a dedicated pharmaceutical facility that can cater to all temperature band requirements, from +20Cº storage for PPE and medical equipment, to -90 Cº deep freezer capabilities to predominantly cater for vaccine storage and handling.

Commenting on the agreement, Rashed Saif Al Qubaisi, Chief Executive Officer of Rafed, said: “As part of the efforts exerted to support the global supply of COVID-19 vaccines, this agreementis amongst the many big steps towards our Consortium partnership efforts in developing the operational and logistical synergies between our companies to secure the management, transportation, and storage of the COVID-19 vaccines ensuring timely deliveries and world-class distribution systems in the near-future. We’re glad to be partnering with G42 Healthcare on this important mission serving humanity during this COVID-19 worldwide pandemic.”

Furthermore, Ashish Koshy, G42 Healthcare CEO commented: “This partnership further cements G42 Healthcare’s roleas a key global player leading the charge against a virus that has crippled the world. The agreement allows for all the cold chain warehousing and logistical requirements to be met while ensuring that vaccines are handled with utmost precision and in compliance with international safety standards. We see this as the first step in what will prove to be a long-term partnership with all other members of the Hope Consortium, as we stand connected in our shared vision of a COVID-19 free world.”

Rafed has also recently announced that the company signed a collaboration agreement with Abu Dhabi Ports to jointly launch the largest healthcare and medical supplies cold store distribution centre in the UAE. Under the strategic collaboration agreement, Abu Dhabi Ports will deliver a state-of-the-art warehouse and inventory management solution for upstream, midstream and downstream operations as Rafed’s fourth-party logistics service provider. The new distribution centre will be the largest, most technologically advanced centre in the UAE.

About Rafed:

Rafed aims to ensure the availability and quality of healthcare supplies and products for Abu Dhabi’s healthcare sector, which include pharmaceuticals, equipment, diagnostics and consumables, and to reduce operating costs for healthcare providers.

As a Group Purchasing Organization (GPO), Rafed specializes primarily in healthcare procurement which includes supplier sourcing and contract management, procurement ordering services, warehousing, and distribution.

Rafed was developed by ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.  

For further information on Rafed, contact rafed.info@rafeduae.ae

Media Contacts:
Mohammad Zaki, Action Global Communications (Rafed)
Direct: +971 501510150
Email: rafed@actionprgroup.com

About G42 Healthcare

G42 Healthcare, a subsidiary of Abu Dhabi-based Group 42 – a leading technology company, is committed to developing a world-class, sustainable healthcare sector in the UAE and abroad. At the forefront in the battle against COVID-19, G42 Healthcare has partnered with health authorities in Abu Dhabi and specialized medical facilities to establish a massive throughput testing laboratory in 14 days and contribute to the trial effort of the UAE.

G42 Healthcare uses its advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company has also developed its PPE manufacturing capacity.

Beyond COVID-19, G42 Healthcare has developed a program of activities to support the health of future generations – ranging from genomics, imaging and diagnostics to digitization programs, manufacturing and cutting-edge research.

For further information on G42, visit www.g42.ai.